Guangdong VTR Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 7.45%

Guangdong VTR Bio-Tech Co Ltd (300381) has an Asset Resilience Ratio of 7.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Guangdong VTR Bio-Tech Co Ltd (300381) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥215.61 Million

≈ $31.55 Million USD Cash + Short-term Investments

Total Assets

CN¥2.89 Billion

≈ $423.60 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Guangdong VTR Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. See what is Guangdong VTR Bio-Tech Co Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangdong VTR Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Guangdong VTR Bio-Tech Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥215.61 Million	7.45%
Total Liquid Assets	CN¥215.61 Million	7.45%

Asset Resilience Insights

Limited Liquidity: Guangdong VTR Bio-Tech Co Ltd maintains only 7.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong VTR Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong VTR Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Guangdong VTR Bio-Tech Co Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Guangdong VTR Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.26%	CN¥332.13 Million ≈ $48.60 Million	CN¥2.95 Billion ≈ $431.47 Million	-6.95pp
2023-12-31	18.21%	CN¥563.70 Million ≈ $82.49 Million	CN¥3.09 Billion ≈ $452.89 Million	-3.50pp
2022-12-31	21.72%	CN¥688.89 Million ≈ $100.81 Million	CN¥3.17 Billion ≈ $464.18 Million	+21.56pp
2016-12-31	0.16%	CN¥5.00 Million ≈ $731.66K	CN¥3.21 Billion ≈ $469.70 Million	-12.30pp
2014-12-31	12.46%	CN¥120.04 Million ≈ $17.57 Million	CN¥963.36 Million ≈ $140.97 Million	--

pp = percentage points

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology

Market Cap

$497.26 Million

CN¥3.40 Billion CNY

Market Cap Rank

#12573 Global

#3917 in China

Share Price

CN¥6.92

Change (1 day)

-0.57%

52-Week Range

CN¥6.11 - CN¥8.17

All Time High

CN¥34.00